20+ years in Europe
IAVI’s Europe hub has been working with partners around the world to build awareness of and support for vaccine and antibody development. The multidisciplinary team, residing in offices in Amsterdam and London, brings together colleagues working in resource mobilization, advocacy, communications, access, epidemiology, immunology, project management, and operations.
- It’s the first time that we have TB vaccines in late-stage development. There’s a lot of enthusiasm in the global health community to ensure that these vaccines are developed, registered, and accessible to high-burden countries and communities. It’s a special time in the TB vaccine space. I am thrilled to be part of this unique moment that we’re in.Gabriela Gomez Senior Director, Global Access
- The LGBTQIA+ community have been leaders in the global HIV response since the very beginning, and the continued and active involvement of LGBTQIA+ people in HIV research is essential if we are to effectively end the epidemic. The need for responsive and inclusive research couldn’t be clearer.Shaun Palmer Communications Specialist
1 of 2